John Johnson, Director: Xeris Biopharma Holdings XERS Planned sale · Filed 06/04

Trade details

Type: Planned sale notice
Stock: Xeris Biopharma Holdings XERS
Person: John JohnsonDirector
Planned sale date: 26/06/04
Filed: 26/06/04

$88.3K to be sold

Xeris Biopharma Holdings trades, last 26 weeks

What else happened in Xeris Biopharma Holdings around then

Filed or reported within 30 days of the trade day · 05/05~07/04

John Johnson's recent trades

John JohnsonDirector
Sell10b5-1 planXeris Biopharma Holdings
Sell10b5-1 plan
Xeris Biopharma Holdings
XERS
$91.4K
15,000 sh
$91.4K
Filed 06/05
Traded 06/04
John JohnsonDirector
SellAxogen
Sell
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/08
Traded 05/07
John JohnsonDirector
Planned saleAxogen
Planned sale
Axogen
AXGN
$478K
11,050 sh
$478K
Filed 05/07
Traded 05/07
John JohnsonDirector
Planned saleXeris Biopharma Holdings
Planned sale
Xeris Biopharma Holdings
XERS
$977K
135,402 sh
$977K
Filed 25/12/19
Traded 25/12/19
John JohnsonDirector
SellXeris Biopharma Holdings
Sell
Xeris Biopharma Holdings
XERS
$977.6K
135,400 sh
$977.6K
Filed 25/12/19
Traded 25/12/19